Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Slowing Down Stock

2392.0000 -27.00 (-1.12%)

NSE Oct 14, 2025 15:31 PM

Near 52W Low of ₹2327.30

Volume: 125.9K

Ajanta Pharma Ltd.

06 May 2023

2392.00

-1.12%

Ajanta Pharma (BUY): Margins appear to have bottomed out; raise to BUY

Buy: Ajanta Pharma Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Strong India and US growth in Q4 (17% YoY each) offset by declines in other businesses

Promoters pledged 1.16% of shares in last quarter. Total pledge stands at 15.28% of promoter holdings